Epidemiological studies suggest that the world's oldest vaccine, the BCG used against tuberculosis, may reduce the risk of coronavirus infection as well as the risk of severe forms of Covid-19 disease. Professor Camille Locht, director of INSERM research at the Pasteur Institute in Lille, France, is the author of this study.
Plus
